3Blomadal, Lofstrom B, Yin L, et al. An increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol, 2002, 31:66-71. 被引量:1
4Kiss E, Kovacs L, Szodoray P, Malignancies in systemic lupus erythematosus. Autoimmun Rev, 2010, 9: 195-199. 被引量:1
6Wundisch T, Thiede C, Morgner A, et al. Long-term fo|lowup of gastric MALT lymphoma after helicobacter pylorieradication. J Clin Oncol, 2005, 23: 8018-8024. 被引量:1
7Bematsky S, Ramsey-Goldman R, Isenberg D, et al. Hodgkin's lymlphoma in systemic lupus erythatosus. Rheumatol (oxford), 2007, 46: 830-832. 被引量:1
8Landgren O, Linet MS, McMaster ML, et al. Familial characteristics of autoimmune and hematologic disorders in 8,406 muhiple myeloma patients: a population-based case-control study. Int J Cancer, 2006, 118: 3095-3098. 被引量:1
9Landgren O, Zhang Y, Zahm SH, et al. Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women. Cancer Epidemiol Biomarkers Prey, 2006, 15: 2342-2347. 被引量:1
10All YM, Urowitz MB, Ibanez D, et al. Monoclonal gammopathy in systemic lupus erythematosus. Lupus, 2007, 16: 426-429. 被引量:1